Physician

Mazen Alakhras, MD

According to 2025 Medicare claims, Mazen Alakhras, MD (NPI: 1285617803) practices pulmonary disease in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is FRANCISCAN PHYSICIAN NETWORK (NPI: 1225327984; TIN: 611630276) and primary practice location at 47905-4972. Alakhras is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550) and Ascension Care Management (ACO ID: A2600), participating under the MSSP model.

Alakhras' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 808 traditional Medicare patients, billed 2,607 HCPCS/CPT codes, and received $175,579 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,891 prescription claims across 411 beneficiaries totaling $1,779,561 in drug costs, led by Wakix (Pitolisant Hcl). DME data shows 3,911 claims. Open Payments data shows 3 records totaling $65. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $7,615 to $175,579. Similarly, Part D prescription costs have moved sharply higher in recent years, from $53,855 to $1,779,561. For DME billing, reported payments moved sharply higher in recent years, from $54,153 to $183,360.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$103K$207K2016 Medicare payment: $7,615 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $59,696 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $168,190 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $159,844 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $206,925 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $158,230 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $183,575 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $175,579 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20163587$7,615
2017N/RN/RN/R
2018228804$59,696
20195562,239$168,190
20205541,948$159,844
20216832,447$206,925
20226152,071$158,230
20236792,431$183,575
20248082,607$175,579

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$890K$1.8M2015 Drug cost: $53,855 (USD; Tot_Drug_Cst)2018 Drug cost: $16,111 (USD; Tot_Drug_Cst)2019 Drug cost: $123,244 (USD; Tot_Drug_Cst)2020 Drug cost: $272,213 (USD; Tot_Drug_Cst)2021 Drug cost: $508,183 (USD; Tot_Drug_Cst)2022 Drug cost: $861,131 (USD; Tot_Drug_Cst)2023 Drug cost: $1,478,169 (USD; Tot_Drug_Cst)2024 Drug cost: $1,779,561 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201553237$53,855
2016N/RN/RN/R
2017N/RN/RN/R
20182044$16,111
2019130515$123,244
20201791,087$272,213
20212521,597$508,183
20223011,953$861,131
20233492,284$1,478,169
20244112,891$1,779,561

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$160K$320K2015 Medicare payment: $81,634 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,519 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $4,661 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,193 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $129,685 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $181,289 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $234,643 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $249,510 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $291,593 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $319,987 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015282977$81,634
2016125310$13,519
201781175$4,661
201853165$4,193
20195361,612$129,685
20206332,046$181,289
20216492,480$234,643
20228253,010$249,510
20231,1383,432$291,593
20241,2873,911$319,987

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes117230$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more388485$79
95806Sleep study including heart rate, breathing, airflow, and effort127127$31
94729Test to examine how well the lungs exchange gases133135$20
94010Test to measure expiratory airflow and volume259282$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
WakixPitolisant Hcl24720$369,995
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45316,740$356,592
OfevNintedanib Esylate23690$330,667
Breztri AerosphereBudesonide/Glycopyr/Formoterol2077,408$154,310
Dupixent SyringeDupilumab26728$107,663

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgramN21144$112,196
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY44288$28,848
A7031Face mask interface, replacement for full face mask, eachN73176$18,318
A7030Full face mask used with positive airway pressure device, eachN76161$16,784
E0601Continuous positive airway pressure (cpap) deviceY68296$15,382

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$65GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mazen Alakhras, MD?

Tedicare shows public-source Medicare data for Mazen Alakhras, MD (NPI 1285617803), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mazen Alakhras, MD have ACO affiliation data?

Mazen Alakhras, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550) and Ascension Care Management (MSSP, ACO ID A2600).

What billing organization is linked to Mazen Alakhras, MD?

Mazen Alakhras, MD is linked to FRANCISCAN PHYSICIAN NETWORK (billing NPI 1225327984) in the available physician profile data.

Does Mazen Alakhras, MD have Open Payments data?

Mazen Alakhras, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.